Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istaroxime in acute decompensated heart failure
2013-000540-26Phase 2Completed
- Sponsor
- CVie Therapeutics
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of istaroxime in heart failure (HF) and Acute Heart Failure (AHF) (3 arms), sponsored by CVie Therapeutics. Primary endpoint: Change in E/Ea ratio at 24 hours. Started Mar 2013; status: completed.
02
Drugs
istaroxime
03
Conditions
heart failure (HF)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2013-000540-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000540-26.